U.S. drug agents are expanding operations in China – six years after America’s largest trading partner and global rival emerged as the main source of chemicals used to make highly lethal fentanyl. It’s now claiming 65,000 American lives a year.
The small crew of about a dozen Drug Enforcement Administration agents, including those in new outposts in Shanghai and Guangzhou, is nearly double the number in 2018. They face what seems like mission impossible: collaborating with Chinese agents to try to bust traffickers hidden somewhere in a sprawling export supply chain that’s linked to 160,000 companies.
“It’s such a massive chemical industry, and then there are layer upon layer of traders, brokers and freight forwarders,” says Russ Holske, the DEA’s director for the Far East, who set up the new offices in China before he retired. “It’s a daunting challenge.”
Read More